Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of malignant pleural effusions.

S A Sahn1

  • 1Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, Charleston, South Carolina, USA. sahnsa@musc.edu

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|March 13, 2002
PubMed
Summary

Malignant pleural effusions, common in lung and breast cancer, cause dyspnea. Effective palliation involves assessing the patient and choosing the least invasive treatment, like chemical pleurodesis with talc slurry, for optimal quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013
Same author

Malignant pleural effusions.

Seminars in respiratory and critical care medicine·2005
Same author

Trapped lung.

Seminars in respiratory and critical care medicine·2005
Same author

Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria.

Thorax·2001
Same author

Management of malignant pleural effusions.

The European respiratory journal·2001
Same author

Resolution of pleural effusions.

Chest·2001

Area of Science:

  • Pulmonology
  • Oncology
  • Palliative Care

Background:

  • Malignant pleural effusions (MPEs) are common in advanced lung and breast cancer.
  • MPEs significantly impact patient quality of life, primarily through dyspnea.

Purpose of the Study:

  • To review current palliative treatment options for malignant pleural effusions.
  • To emphasize patient assessment for selecting the most effective and least invasive therapy.

Main Methods:

  • Review of therapeutic modalities for MPE palliation.
  • Discussion of chemical pleurodesis, indwelling catheters, and surgical options.
  • Analysis of factors influencing treatment selection, including patient status and response to initial procedures.

Main Results:

Related Experiment Videos

  • Chemical pleurodesis, particularly talc slurry, is highly effective for MPE palliation.
  • Chronic indwelling catheters offer an alternative, and pleuroperitoneal shunting benefits specific cases.
  • Parietal pleurectomy is reserved for refractory cases or trapped lungs.

Conclusions:

  • Optimal palliation of MPEs requires comprehensive patient assessment and selection of the least invasive, morbid, and costly therapy.
  • Successful initial treatment is crucial to minimize patient burden and healthcare costs.